[Tiger’s Weekly Intel] – VB Spine’s acquisition, Movmedix’s FDA clearance, and Miach’s clinical data.

Most of the industry is reading self-serving press releases, but here is your intel on what really happened last week.

Weekly Overview: Key Advancements and Acquisitions Shaping Spine and Tissue Tech Over the past week (July 4–11, 2026), commercial and strategic activity centered on high-impact clinical data milestones, regulatory clearances for synthetic soft tissue solutions, and highly targeted technology acquisitions designed to enhance navigation and imaging in spine procedures. Trends The overarching structural driver remains the steady shift of high-volume procedures, such as total knee arthroplasty (TKA) and total hip arthroplasty (THA), from traditional hospital outpatient departments to independent ASCs [7]. This macro shift creates an intense market pull for compact, efficient systems in navigation, robotics, fixation, and orthobiologics that minimize physical footprints, lower capital acquisition costs, and optimize rapid clinical workflows. Nav / Imaging In the fields of surgical navigation and intraoperative imaging, smaller and emerging companies are capturing a competitive edge by advancing hybrid solutions that blend comprehensive preoperative planning with intr...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top